Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

China Biologic Products - Barchart's Chart Of The Day

|Includes: China Biologic Products Holdings, Inc. (CBPO)

The Chart of the Day belongs to China Biologic Products (NASDAQ:CBPO). I found the stock by sorting the All Time High list for the stocks having the highest technical buy signals, then used the Flipcahrt feature to review the stocks. Since the Trend Spotter signaled a buy on 1/7 the stock gained 40.16%.

China Biologic Products, Inc., through its indirect majority-owned subsidiary, is principally engaged in the research, development, production, manufacturing and sale of plasma-based biopharmaceutical products to hospitals and other health care facilities in China. Its subsidiary, Shandong Taibang Biological Products Co. Ltd., operates from its manufacturing facility located in Taian City, Shandong Province. The Company's principal products include its approved human albumin and immunoglobulin products. These human albumin products are mainly used to increase blood volume and its immunoglobulin products are used for the treatment and prevention of diseases.

Barchart technical indicators:

  • 100% Barchart technical buy signals
  • Trend Spotter buy signal
  • Above its 20, 50 and 100 day moving averages
  • 12 new highs and up 25.70% in the last month
  • Relative Strength Index 79.87%
  • Barchart computes a technical support level at 90.53
  • Recently traded at 96.83 with a 50 day moving average of 77.13

Fundamental factors:


  • Market Cap $2.37 billion
  • P/E 30.53
  • Revenue expected to grow 19.00% this year and another 15.60% next year
  • Earnings estimated to increase 23.60% this year, an additional 21.50% next year and continue to compound at an annual rate of 16.00% for the next 5 years
  • Wall Street analysts issued 2 strong buy and 2 by recommendations for the stock

The 50-100 Day MACD Oscillator has been a reliable technical trading strategy and should be continue to be used to determine entry and exit points.